Airja (Ar•yAh)

Our mission is to bring confidence, accuracy, and convenience to respiratory drug delivery.

Our founding team is proud to have launched multiple, successful companies over the last 20 years. We are at it again applying the same business and technology know-how to Airja’s innovative vaporizing solutions.

Respiratory drug delivery technology in both pharmaceutical and recreational markets.

Airja is an intellectual property and product development company that commercializes and licenses novel respiratory drug delivery technology in both pharmaceutical and recreational markets (nicotine, cannabinoids). Airja currently has a business unit commercializing products in the cannabinoid products. Additionally, Airja is investigating many pharmaceutical compounds and indications for potential products.

Airja Products:

• Incorporate patent-protected technology to generate precise condensation aerosols, with appropriate characteristics (e.g., aerosol particle size, dose control) for the effective delivery of compounds to the deep lung, to treat a number of conditions.

• Employ a processor-controlled dispensing method, along with a proprietary heating system to consistently create a reproducible, predictable dose.

  This new vaporization technology comes with opportunities to deliver superior products within cannabinoid markets, along with multiple pharmaceuticals where rapid Pharmacokinetics (PK) are required or where injection administration is not possible or desired.